Company profile: Orgentec
1.1 - Company Overview
Company description
- Provider of laboratory autoimmune diagnostic solutions, developing, producing and marketing test systems including more than 200 ELISA test systems, blot and immunofluorescence tests, and fully automated ELISA analyzers Alegria and Alegria 2 using SMC technology for in-vitro diagnostics. Applications include autoimmune and infectious diseases such as rheumatic, thrombosis, vasculitis, diabetes, and gastrointestinal disorders.
Products and services
- ELISA Test Systems: ORGENTEC engineers more than 200 highly specific ELISA assays for autoimmune diagnostics, covering rheumatic, thrombosis, vasculitis, diabetes, and gastrointestinal disorders, laboratory-grade
- Alegria® 2: An advanced, laboratory-grade platform delivering enhanced automation and flexible workflows for laboratory diagnostics focused on autoimmune and infectious diseases within the Alegria® system lineage
- Alegria®: A fully automated, industrial-grade ELISA analyzer for in‑vitro diagnostics, utilizing SMC® technology to conduct autoimmune disease determinations through test strips in laboratory environments
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Orgentec
ProciseDx
HQ: United States
Website
- Description: Provider of point-of-care diagnostic solutions for physician offices, retail clinics, and urgent care, delivering rapid, lab-quality results. Offerings include tests for infliximab (Procise IFX), adalimumab (Procise ADL), C-reactive protein (Procise CRP), fecal calprotectin (Procise FCP), and the ProciseDx Instrument for quantitative immunoassays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProciseDx company profile →
Immunodiagnostic Systems
HQ: United Kingdom
Website
- Description: Provider of in-vitro diagnostic solutions for clinical and research laboratories, including the IDS-iSYS multi-discipline automated system, automated and manual immunoassays, endocrinology and autoimmunity assay portfolios, and therapeutic drug monitoring. Development focuses on bone and calcium metabolism, growth, hypertension, and chronic kidney disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunodiagnostic Systems company profile →
Roche
HQ: Switzerland
Website
- Description: Provider of pharmaceuticals and in-vitro diagnostics, including diagnostic tests and instruments for cancer, diabetes, and infectious diseases; develops medicines for oncology, neurology, virology, inflammation, metabolism, CNS, ophthalmology, immunology, and transplantation; offers digital health solutions for virtual care, decision support, and self-monitoring, plus diabetes management devices and services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Roche company profile →
Spinreact
HQ: Spain
Website
- Description: Provider of biotechnology research and development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spinreact company profile →
General Fluidics
HQ: United States
Website
- Description: Provider of the Axess Diagnostic Platform, an in vitro point-of-care testing solution that integrates hematology, clinical chemistry, and immunoassay tests for blood and urine, streamlining the testing process from sample collection to result delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full General Fluidics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Orgentec
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Orgentec
2.2 - Growth funds investing in similar companies to Orgentec
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Orgentec
4.2 - Public trading comparable groups for Orgentec
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →